Gene therapy may have also a therapeutic potential especially for Leber’s hereditary optic neuropathy, an optic neuropathy caused by mitochondrial mutation G11778A in NADH dehydrogenase subunit 4 (ND4) gene [332]. Here, MT-ND4 is linked to Optic neuropathy.